These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 10924989

  • 1. Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: baseline results to compare new strategies.
    Barillot I, Horiot JC, Maingon P, Truc G, Chaplain G, Comte J, Brenier JP.
    Int J Radiat Oncol Biol Phys; 2000 Aug 01; 48(1):189-200. PubMed ID: 10924989
    [Abstract] [Full Text] [Related]

  • 2. Organ preservation in cervix cancer.
    Barillot I, Bone-Lepinoy MC, Horiot JC, Maingon P, Chaplain G, D'Hombres A, Comte J.
    Rays; 1997 Aug 01; 22(3):410-6. PubMed ID: 9446945
    [Abstract] [Full Text] [Related]

  • 3. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
    Lee SW, Suh CO, Chung EJ, Kim GE.
    Int J Radiat Oncol Biol Phys; 2002 Apr 01; 52(5):1338-44. PubMed ID: 11955747
    [Abstract] [Full Text] [Related]

  • 4. High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications.
    Ferrigno R, dos Santos Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Gentil AC, Salvajoli JV.
    Int J Radiat Oncol Biol Phys; 2001 Aug 01; 50(5):1123-35. PubMed ID: 11483321
    [Abstract] [Full Text] [Related]

  • 5. Radiotherapy alone in the treatment of uterine cervix cancer with telecobalt and low-dose-rate brachytherapy: retrospective analysis of results and variables.
    Ferrigno R, Campos de Oliveira Faria SL, Weltman E, Salvajoli JV, Segreto RA, Pastore A, Nadalin W.
    Int J Radiat Oncol Biol Phys; 2003 Mar 01; 55(3):695-706. PubMed ID: 12573757
    [Abstract] [Full Text] [Related]

  • 6. High dose rate brachytherapy for carcinoma of the cervix: risk factors for late rectal complications.
    Uno T, Itami J, Aruga M, Kotaka K, Fujimoto H, Sato T, Minoura S, Ito H.
    Int J Radiat Oncol Biol Phys; 1998 Feb 01; 40(3):615-21. PubMed ID: 9486611
    [Abstract] [Full Text] [Related]

  • 7. Carcinoma of the uterine cervix. II. Lack of impact of prolongation of overall treatment time on morbidity of radiation therapy.
    Perez CA, Grigsby PW, Castro-Vita H, Lockett MA.
    Int J Radiat Oncol Biol Phys; 1996 Jan 01; 34(1):3-11. PubMed ID: 12118562
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens.
    Wong FC, Tung SY, Leung TW, Sze WK, Wong VY, Lui CM, Yuen KK, O SK.
    Int J Radiat Oncol Biol Phys; 2003 Apr 01; 55(5):1254-64. PubMed ID: 12654435
    [Abstract] [Full Text] [Related]

  • 11. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R, Knocke TH, Fellner C, Baldass M, Reinthaller A, Kucera H.
    Cancer Radiother; 2000 Apr 01; 4(2):159-72. PubMed ID: 10812362
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for local tumor control and early recurrences.
    Sorbe B, Bohr L, Karlsson L, Bermark B.
    Int J Oncol; 2010 Feb 01; 36(2):371-8. PubMed ID: 20043071
    [Abstract] [Full Text] [Related]

  • 15. Treatment outcome of medium-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: comparison with low-dose-rate intracavitary brachytherapy.
    Kaneyasu Y, Kita M, Okawa T, Maebayashi K, Kohno M, Sonoda T, Hirabayashi H, Nagata Y, Mitsuhashi N.
    Int J Radiat Oncol Biol Phys; 2012 Sep 01; 84(1):137-45. PubMed ID: 22285665
    [Abstract] [Full Text] [Related]

  • 16. An audit of the treatment of carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique.
    Tan LT, Jones B, Gee A, Kingston RE.
    Br J Radiol; 1997 Dec 01; 70(840):1259-69. PubMed ID: 9505845
    [Abstract] [Full Text] [Related]

  • 17. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.
    Atlan D, Touboul E, Deniaud-Alexandre E, Lefranc JP, Antoine JM, Jannet D, Lhuillier P, Uzan M, Huart J, Genestie C, Antoine M, Jamali M, Ganansia V, Milliez J, Uzan S, Blondon J.
    Int J Radiat Oncol Biol Phys; 2002 Nov 01; 54(3):780-93. PubMed ID: 12377330
    [Abstract] [Full Text] [Related]

  • 18. Pulsed low dose rate brachytherapy for uterine cervix carcinoma.
    Rogers CL, Freel JH, Speiser BL.
    Int J Radiat Oncol Biol Phys; 1999 Jan 01; 43(1):95-100. PubMed ID: 9989519
    [Abstract] [Full Text] [Related]

  • 19. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy.
    Cheng JC, Peng LC, Chen YH, Huang DY, Wu JK, Jian JJ.
    Int J Radiat Oncol Biol Phys; 2003 Nov 15; 57(4):1010-8. PubMed ID: 14575832
    [Abstract] [Full Text] [Related]

  • 20. Are doses to ICRU reference points valuable for predicting late rectal and bladder morbidity after definitive radiotherapy in uterine cervix cancer?
    Kim HJ, Kim S, Ha SW, Wu HG.
    Tumori; 2008 Nov 15; 94(3):327-32. PubMed ID: 18705399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.